Pfizer’s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading on Wall Street today, renewing investors’ concerns over the pharmaceutical sector.

Investors, shifting their focus from the economy to a possible second-half profit slump, sent technology and small-cap stocks sharply lower today, moving Wall Street toward another losing week.